The Africa bioanalytical testing services market is projected to register a substantial CAGR of 6.8% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2021, and the forecast period is 2022 to 2029.
Market Segmentation: Africa Bioanalytical Testing Services Market, By Type (Bioanalytical Services For Preclinical and Clinical Studies, Small Molecule Bioanalytical Services, and Large Molecule Bioanalytical Services), End User (Clinical Research Organizations, Pharmaceutical and Biotechnology Companies, Hospitals Labs, Academic and Research Institutes, and Others), Country (South Africa, Angola, Ethiopia, Nigeria, and Rest of Africa) Industry Trends and Forecast to 2029
Some of the significant factors contributing to the growth of Africa bioanalytical testing services are:
Rise in focus on the analytical testing of biologics and biosimilar Increase in preference for outsourcing analytical testing
Market Players:
Some of the major players operating in the Africa bioanalytical testing services market are:
FARMOVS (PTY) LTD SGS SA Labcorp Synexa Life Sciences BV Q2 Solutions. Medpace BARC SOUTH AFRICA Merieux NutriSciences Corporation
TABLE OF CONTENT
TABLE OF CONTENTS
1 INTRODUCTION 11
1.1 OBJECTIVES OF THE STUDY 11
1.2 MARKET DEFINITION 11
1.3 OVERVIEW OF AFRICA BIOANALYTICAL TESTING SERVICES MARKET 11
1.4 LIMITATIONS 12
1.5 MARKETS COVERED 13
2 MARKET SEGMENTATION 14
2.1 MARKETS COVERED 14
2.2 GEOGRAPHICAL SCOPE 15
2.3 YEARS CONSIDERED FOR THE STUDY 15
2.4 CURRENCY AND PRICING 15
2.5 DBMR TRIPOD DATA VALIDATION MODEL 16
2.6 MULTIVARIATE MODELLING 19
2.7 TYPE LIFELINE CURVE 19
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 20
2.9 DBMR MARKET POSITION GRID 21
2.10 MARKET END USER COVERAGE GRID 22
2.11 VENDOR SHARE ANALYSIS 23
2.12 SECONDARY SOURCES 24
2.13 ASSUMPTIONS 24
3 EXECUTIVE SUMMARY 25
4 PREMIUM INSIGHTS 27
4.1 PORTER'S FIVE FORCES 28
4.2 PESTEL ANALYSIS 29
5 AFRICA BIOANALYTICAL TESTING SERVICES MARKET: REGULATIONS 30
5.1 REGULATION IN AFRICA: 30
5.1.1 GUIDELINES FOR BIOANALYTICAL TESTING SERVICES BY SAHPRA: 30
6 MARKET OVERVIEW 32
6.1 DRIVERS 34
6.1.1 RISE IN FOCUS ON THE ANALYTICAL TESTING OF BIOLOGICS AND BIOSMILARS 34
6.1.2 INCREASE IN PREFERENCE FOR OUTSOURCING ANALYTICAL TESTING 34
6.1.3 GROWING R&D EXPENDITURE IN THE PHARMACEUTICAL AND BIOPHARMACEUTICAL INDUSTRY 35
6.2 RESTRAINTS 35
6.2.1 DEARTH OF SKILLED PROFESSIONALS 35
6.2.2 PRICING PRESSURE FACED BY MAJOR PLAYERS 35
6.3 OPPORTUNITIES 36
6.3.1 RISE IN ADOPTION OF THE QUALITY BY DESIGN APPROACH 36
6.3.2 RISE IN DEMAND FOR SPECIALIZED BIOANALYTICAL TESTING SERVICES 36
6.3.3 STRATEGIC INITIATIVES OF KEY PLAYERS 37
6.4 CHALLENGES 37
6.4.1 INNOVATIVE FORMULATIONS DEMANDING A UNIQUE BIOANALYTICAL TESTING APPROACH 37
6.4.2 GROWING NEED TO IMPROVE THE SENSITIVITY OF BIOANALYTICAL METHODS 38
7 AFRICA BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE 39
7.1 OVERVIEW 40
7.2 BIOANALYTICAL SERVICES FOR PRECLINICAL AND CLINICAL STUDIES 42
7.2.1 PHARMACOKINETIC (PK) ANALYSIS 43
7.2.2 BIOEQUIVALENCE STUDIES 43
7.2.3 BIOAVAILABILITY STUDIES 43
7.2.4 METHOD DEVELOPMENT & VALIDATION 43
7.2.5 LEAD OPTIMIZATION STUDIES 43
7.2.6 DOSE FORMULATION ANALYSIS 44
7.2.7 BIOANALYTICAL TECHNOLOGIES 44
7.2.8 OTHERS 44
7.3 SMALL MOLECULE BIOANALYTICAL SERVICES 44
7.3.1 METHOD DEVELOPMENT & VALIDATION 45
7.3.2 METABOLITE IDENTIFYING & SCREENING 45
7.3.3 SUPPORT FOR PRE-CLINICAL ANIMAL STUDIES 45
7.3.4 DRIED BLOOD SPOT ANALYSIS 45
7.3.5 TISSUE BIOANALYSIS 45
7.3.6 HAZARDOUS SAMPLE LABORATORY FOR HIV & HEPATITIS-B 45
7.3.7 BIOMARKERS ASSAY 46
7.3.8 OTHERS 46
7.4 LARGE MOLECULE BIOANALYTICAL SERVICES 46
7.4.1 IMMUNOCHEMISTRY SERVICES 47
7.4.2 BIOMARKER ASSAYS 47
7.4.3 METABOLITE IDENTIFYING & SCREENING 47
7.4.4 QUANTITATIVE IMMUNOASSAYS 47
7.4.5 IMMUNOGENICITY ASSAYS 47
7.4.6 PHARMACOKINETICS (PK) ANALYSIS 47
7.4.7 LIGAND-BINDING ASSAYS 48
7.4.8 OTHERS 48
8 AFRICA BIOANALYTICAL TESTING SERVICES MARKET, BY END USER 49
8.1 OVERVIEW 50
8.2 CLINICAL RESEARCH ORGANIZATIONS 52
8.3 ACADEMIC AND RESEARCH INSTITUTES 53
8.4 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 53
8.5 HOSPITALS LABS 54
8.6 OTHERS 54
9 AFRICA BIOANALYTICAL TESTING SERVICES MARKET, BY COUNTRY 55
9.1 SOUTH AFRICA 60
9.2 NIGERIA 63
9.3 ETHIOPIA 66
9.4 ANGOLA 69
9.5 REST OF AFRICA 72
10 AFRICA BIOANALYTICAL TESTING SERVICES MARKET: COMPANY LANDSCAPE 73
10.1 COMPANY SHARE ANALYSIS: AFRICA 73
11 SWOT ANALYSIS 74
12 COMPANY PROFILE 75
12.1 LABCORP 75
12.1.1 COMPANY SNAPSHOT 75
12.1.2 REVENUE ANALYSIS 75
12.1.3 PRODUCT PORTFOLIO 76
12.1.4 RECENT DEVELOPMENTS 76
12.2 FARMOVS (PTY) LTD 77
12.2.1 COMPANY SNAPSHOT 77
12.2.2 PRODUCT PORTFOLIO 77
12.2.3 RECENT DEVELOPMENTS 77
12.3 SGS SA 78
12.3.1 COMPANY SNAPSHOT 78
12.3.2 REVENUE ANALYSIS 78
12.3.3 PRODUCT PORTFOLIO 79
12.3.4 RECENT DEVELOPMENTS 79
12.4 BARC SOUTH AFRICA 80
12.4.1 COMPANY SNAPSHOT 80
12.4.2 PRODUCT PORTFOLIO 80
12.4.3 RECENT DEVELOPMENTS 80
Short Description
Africa Bioanalytical Testing Services Market, By Type (Bioanalytical Services For Preclinical And Clinical Studies, Small Molecule Bioanalytical Services and Large Molecule Bioanalytical Services), End User (Clinical Research Organization, Pharmaceutical and Biotechnology Companies, Hospital Labs, Academic and Research Institutes, and Others ), Country (South Africa, Angola, Ethiopia, Nigeria, and Rest of Africa) Industry Trends and Forecast to 2029
Market Definition:
The phrase "bioanalysis" often refers to quantitatively analyzing a substance (drug) or its metabolite in biological fluids, primarily blood, plasma, serum, urine, or tissue extracts. Among the methods frequently employed in bioanalytical studies are mass spectrometry using liquid chromatography, gas chromatography-mass spectrometry (GC-MS), Liquid chromatography-diode array detection, or LC-DAD, using mass spectrometry and capillary electrophoresis, or CE-MS, chromatographical procedures HPLC (high-performance liquid chromatography), GC (gas chromatography), UPLC (ultra-performance liquid chromatography), chromatography using supercritical fluid Electrophoresis, Assays for ligand binding, Interferometry with dual polarisation, ELISA (enzyme-linked immunosorbent assay),MIA (magnetic immunoassay) RIA (radioimmunoassay), mass spectrometric, atomic magnetic resonance. The most popular methods are enzyme-linked immunosorbent assay (ELISA) for macromolecules and liquid chromatography combined with tandem mass spectrometry (LC-MS/MS) for "small" compounds.
Market Segmentation:
Africa bioanalytical testing services market is categorized into two notable segments, which are based on type, and end user.
On the basis of type, the Africa bioanalytical testing services market is segmented into bioanalytical services for preclinical and clinical studies, small molecule bioanalytical services, and large molecule bioanalytical services
On the basis of end user, the Africa bioanalytical testing services market is segmented into clinical research organizations, pharmaceutical and biotechnology companies, hospital labs, academic and research institutes, and others
Market Players
The key market players for Africa bioanalytical testing services market are listed below:
FARMOVS (PTY) LTD
Labcorp
BARC SOUTH AFRICA
Synexa Life Sciences BV
Q2 Solutions.
Medpace
SGS SA
Merieux NutriSciences Corporation
Methodology
Why Choose Us
24 * 7 Access to Analyst :
Get your pre and post sales queries resolved by our Subject matter experts.
Customization :
We will assist you to customize the report to fit your research needs.
Assured Quality :
Our prime focus is to provide qualitative and accurate data.
Free sample report :
Feel free to order a sample report before purchase.
Security :
Your personal and confidential information is safe and secured.
